Stock Markets May 10, 2026 05:42 PM

Cerebras to Lift IPO Price Range to $150-$160 as Investor Demand Escalates

AI-driven chipmaker expands offering size amid heavy order interest; listing would be the largest IPO globally so far this year

By Marcus Reed

Cerebras Systems is preparing to raise both the price range and the number of shares in its planned initial public offering, with a new target range of $150-$160 per share and 30 million shares on offer. The move reflects strong investor appetite for the AI chipmaker amid broader surge in demand for high-performance chips, and would boost the potential proceeds at the top end to about $4.8 billion ahead of a planned May 13 pricing.

Cerebras to Lift IPO Price Range to $150-$160 as Investor Demand Escalates

Key Points

  • Cerebras is considering a new IPO range of $150-$160 per share and increasing shares to 30 million from 28 million, which would raise up to about $4.8 billion at the top of the range.
  • The proposed expansion comes amid a surge in AI adoption that has increased demand for high-performance chips and created supply bottlenecks in semiconductors.
  • Orders for the IPO reportedly exceed supply by more than 20 times; Cerebras plans to price the offering on May 13 and intends to list under the symbol CBRS on the Nasdaq Global Select Market.

Cerebras Systems is expected to expand the scale and price band of its forthcoming initial public offering as investor demand continues to climb, according to people briefed on the situation. The chipmaker is considering a revised IPO range of $150 to $160 per share, up from its previous $115 to $125 band, while increasing the number of shares to be marketed to 30 million from 28 million.

At the top of the newly contemplated range, Cerebras would raise roughly $4.8 billion, compared with about $3.5 billion under its initial terms. Those figures remain subject to change prior to final pricing, the people said. The company has set a target to price the offering on May 13.

The proposed expansion of the deal follows a wider upswing in demand for high-performance semiconductors as artificial intelligence adoption accelerates. That shift has elevated the value of specialized processors and has turned semiconductors into a key bottleneck across parts of the technology supply chain.

Orders for Cerebras' IPO have reportedly exceeded available shares by more than 20 times, underscoring intense investor interest as the company prepares to manage demand ahead of pricing. The firm did not immediately respond to requests for comment.

Earlier reports had indicated the company might lift the range to $125 to $135 per share. Cerebras, which is based in Sunnyvale, California, develops specialized chips designed to run advanced AI models. The company competes in a market long dominated by Nvidia, and its processors are said to be particularly well-suited to inference workloads - the computations that allow trained models to respond to user queries - as opposed to the GPU chips commonly used for model training.

The planned IPO would mark Cerebras' second public offering attempt. The company first filed for an IPO in 2024 but pulled that effort last year. Its business and revenue mix have attracted regulatory scrutiny in the past: a partnership with G42, a United Arab Emirates-based AI company that accounted for more than 80% of Cerebras' revenue in the first half of 2024, prompted a review by the Committee on Foreign Investment in the United States. That review ultimately cleared the transaction.

Since clearing that regulatory hurdle, Cerebras has added major AI infrastructure customers, including Amazon and OpenAI. If completed under the expanded terms, the listing would be the largest initial public offering globally so far this year, according to Dealogic.

The offering is being led by Morgan Stanley, Citigroup, Barclays and UBS Group AG. Cerebras intends to list its shares on the Nasdaq Global Select Market under the ticker symbol CBRS.


Context and market implications

The move to raise the price range and share count reflects two intersecting themes that are evident in the current market for AI infrastructure. First, investor appetite for companies tied to AI compute is strong, as evidenced by oversubscription metrics reported for this deal. Second, the growth in demand for inference-optimized chips highlights a shift in customer needs as AI deployments move from model training toward broader model use in production environments.

For markets and sectors, the immediate impacts center on semiconductors and AI infrastructure providers, while capital markets will watch whether the upsized offering sustains through pricing. Cloud and AI service providers that purchase inference capacity are also relevant stakeholders given Cerebras' reported customer wins.

Risks

  • The final size and price of the offering remain subject to change before pricing, creating uncertainty for investors and capital markets.
  • Concentration risk in revenue: a partnership with G42 accounted for more than 80% of Cerebras' revenue in the first half of 2024, a dynamic that previously triggered a Committee on Foreign Investment in the United States review.
  • Market and competitive risk: the company operates in a market dominated by established GPU vendors, and the future performance depends on sustained demand for inference-optimized chips from AI infrastructure customers.

More from Stock Markets

Nvidia CEO Jensen Huang Sees 27% Drop in Total Pay as Stock Awards Lose Value May 12, 2026 Activist Urges BWX Technologies to Revisit Shelved Reactor Plan, Sees Potential for Stock to Double May 12, 2026 S&P Moves Mexico’s Outlook to Negative, Citing Fiscal Strain and Tepid Growth May 12, 2026 Moody's Lowers Everforth Outlook to Negative Amid Elevated Leverage May 12, 2026 Moody's Moves Albemarle Outlook to Stable After Debt Cuts and Stronger Lithium Prices May 12, 2026